Business Context and Reporting Period
Company: Deckers Outdoor Corp.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended September 30, 2001
Business Overview: The company operates three primary reportable segments: Teva, Simple, and Ugg. The period was characterized by a soft economy, weakened retail environments, and a significant litigation charge.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2001 | Nine Months Ended Sep 30, 2001 |
|---|---|---|
| Net Sales | $14.02 million | $70.52 million |
| Gross Profit | $4.75 million (33.9% margin) | $30.08 million (42.7% margin) |
| Net Income (Loss) | $(2.10) million | $1.12 million |
| EPS (Diluted) | $(0.23) | $0.12 |
| Cash and Equivalents | $24.17 million (Sep 30, 2001) | N/A |
| Operating Cash Flow | N/A | $17.94 million |
| Total Debt | $0.55 million | N/A |
| Working Capital | $40.95 million | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 26.9% in the quarter and 21.7% for the nine-month period compared to 2000. This was driven by conservative inventory positions by international distributors, the sale of the Heirlooms subsidiary, and the bankruptcy of a major customer (Track 'n Trail).
- Segment Performance:
- Teva: Sales dropped 45.5% in the quarter and 20.9% year-to-date.
- Simple: Sales dropped 36.4% in the quarter and 30.8% year-to-date.
- Ugg: Sales increased 8.0% in the quarter and 6.9% year-to-date.
- Margin Compression: Gross margins declined due to an increased volume of closeout sales and lower pricing on new product lines. SG&A expenses decreased in absolute dollars but increased as a percentage of sales due to fixed costs.
- Litigation Charge: A special charge of approximately $2.2 million was recorded in the third quarter related to an affirmed judgment in a Montana case. This charge was the primary driver of the quarterly net loss.
- Liquidity Improvement: Cash and cash equivalents increased from $9.06 million at year-end 2000 to $24.17 million at September 30, 2001, driven by strong operating cash flows and reduced inventory levels.
Guidance, Outlook, and Risks
Management Guidance
- Q4 2001: Expected sales of $19–$21 million; expected loss per share of $0.01–$0.02.
- Full Year 2001: Expected sales of $89–$91 million; expected earnings per share of $0.10–$0.11.
- 2002 Outlook: Expected sales of $82–$91 million; expected earnings per share of $0.10–$0.20.
Key Risks and Contingencies
- Litigation Exposure: While a $2.2 million charge was recorded, the company faces potential additional exposure of up to $2.5 million for legal fees and exemplary damages in the Montana case.
- ERP Implementation: The company implemented a new Enterprise Resource Planning system in Q3 but encountered difficulties with functionality, which could impact order processing and inventory management.
- Seasonality and Weather: Sales are highly sensitive to weather conditions (cool springs hurt Teva; warm winters hurt Ugg).
- External Factors: Risks include the impact of the September 11 terrorist attacks, California power outages affecting distribution, and the potential need for significant financing to exercise an option to acquire the Teva brand assets.
Investor Verification Checklist
- Verify the status and potential final cost of the Montana litigation, specifically the risk of the additional $2.5 million exposure.
- Monitor the functionality and stability of the new ERP system and its impact on operational efficiency.
- Assess the sustainability of the Ugg brand's growth versus the continued decline in Teva and Simple sales.
- Review the company's ability to secure financing for the potential Teva acquisition option, which expires in 2003.
- Confirm the impact of the soft retail environment and consumer preference shifts on future closeout sales and gross margins.